PMPCB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.457400E-01
Normal-vs-Stage2
3.559200E-01
Normal-vs-Stage3
3.075800E-02
Normal-vs-Stage4
7.832600E-01
Stage1-vs-Stage2
7.840400E-01
Stage1-vs-Stage3
7.118400E-02
Stage1-vs-Stage4
3.688600E-01
Stage2-vs-Stage3
9.287500E-02
Stage2-vs-Stage4
1.103020E-01
Stage3-vs-Stage4
9.732400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.049800E-01
Normal-vs-AfricanAmerican
4.487800E-01
Normal-vs-Asian
1.953580E-01
Caucasian-vs-AfricanAmerican
9.793400E-01
Caucasian-vs-Asian
9.441700E-02
AfricanAmerican-vs-Asian
3.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.712400E-01
Normal-vs-Female
3.840600E-01
Male-vs-Female
5.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.052000E-01
Normal-vs-Age(41-60Yrs)
4.833800E-01
Normal-vs-Age(61-80Yrs)
3.194400E-01
Normal-vs-Age(81-100Yrs)
5.992400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.139000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.179600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.905200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.135430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.468800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.216000E-01
Normal-vs-Daily Drinker
3.569400E-01
Normal-vs-Weekly Drinker
4.456200E-01
Normal-vs-Occasional Drinker
1.702760E-01
Normal-vs-Social Drinker
9.903600E-01
Non Drinker-vs-Daily Drinker
9.917800E-01
Non Drinker-vs-Weekly Drinker
8.785000E-01
Non Drinker-vs-Occasional Drinker
8.812800E-01
Non Drinker-vs-Social Drinker
7.511700E-02
Daily Drinker-vs-Weekly Drinker
8.963800E-01
Daily Drinker-vs-Occasional Drinker
8.991200E-01
Daily Drinker-vs-Social Drinker
1.053380E-01
Weekly Drinker-vs-Occasional Drinker
9.690600E-01
Weekly Drinker-vs-Social Drinker
1.688020E-01
Occasional Drinker-vs-Social Drinker
5.593900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.395400E-01
Normal-vs-Grade 2
6.664600E-01
Normal-vs-Grade 3
1.309430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.060800E-01
Grade 1-vs-Grade 3
5.262200E-02
Grade 1-vs-Grade 4
3.395400E-01
Grade 2-vs-Grade 3
1.208050E-01
Grade 2-vs-Grade 4
6.664600E-01
Grade 3-vs-Grade 4
1.309430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.651400E-01
Normal-vs-NonDiabetic
3.116600E-01
Diabetic-vs-NonDiabetic
8.854600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.381600E-01
Normal-vs-NoPancreatitis
3.009200E-01
Pancreatitis-vs-NoPancreatitis
2.138600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.584400E-01
Normal-vs-N1
3.155400E-01
N0-vs-N1
2.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.694200E-01
Normal-vs-TP53-NonMutant
6.931600E-01
TP53-Mutant-vs-TP53-NonMutant
8.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
